Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...

There are always new bike bits, bobs, products, and gear to share. This week in tech news comes all over the spectrum of ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel ...

FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)Assuming ...

Marty Makary is one step closer to becoming the head of the Food and Drug Administration. On March 13, the Senate Health, ...

As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the globa ...

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...

The move marks an advancement in reducing plastic waste and assisting global brands in achieving their sustainability ...

A California company offering the world's first injectable CBD product is in hot water after the FDA said the IV injections ...

A groundbreaking study has uncovered new insights into the pain pathways associated with temporomandibular joint (TMJ) disorders.

The patient, a man in his 40s from New South Wales, received the BiVACOR Total Artificial Heart (TAH) during a six-hour ...

The Senate Committee on Health, Labor and Pensions voted Thursday to approve Marty Makary as commissioner of the Food and Drug Administration. He will likely be confirmed in the full Senate.